Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health    CAH

CARDINAL HEALTH

(CAH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period June 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 129 976 136 809 145 534 152 176 158 378 164 245
EBITDA 2 959 2 910 2 732 2 689 2 746 2 775
Operating profit (EBIT) 2 769 2 585 2 353 2 236 2 268 2 350
Pre-Tax Profit (EBT) - -228 1 751 1 261 1 527 1 346
Net income 1 288 256 1 363 1 062 1 109 1 022
P/E ratio 19,3x 60,3x 10,4x 14,4x 13,4x 13,5x
EPS ( $ ) 4,03 0,81 4,53 3,59 3,85 3,82
Dividend per Share ( $ ) 1,81 1,86 1,91 2,00 2,08 2,39
Yield 2,32% 3,82% 4,06% 3,88% 4,03% 4,64%
Reference price ( $ ) 77,920 48,830 47,100 51,540 51,540 51,540
Announcement Date 08/02/2017
11:00am
08/06/2018
10:55am
08/08/2019
10:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period June 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 3 516 7 250 5 500 4 981 4 399 3 593
Finance - - - - - -
Operating income (EBITDA) 2 959 2 910 2 732 2 689 2 746 2 775
Leverage
(Debt/EBITDA)
1,19x 2,49x 2,01x 1,85x 1,60x 1,30x
Capital Expenditure 387 384 328 374 359 360
Free Cash Flow (FCF) 797 2 384 2 394 2 116 2 191 2 258
Book Value Per Share (BVPS) ( $ ) 21,5 19,5 28,9 21,5 22,6 20,6
Cash Flow per Share ( $ ) 3,70 8,79 9,04 6,09 8,22 8,16
Announcement Date 08/02/2017
11:00am
08/06/2018
10:55am
08/08/2019
10:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 15 071 M $ -
Entreprise Value (EV) 20 052 M $ 19 470 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 14,4x 13,4x
Capitalization / Revenue 0,10x 0,10x
EV / Revenue 0,13x 0,13x
EV / EBITDA 7,46x 7,30x
Yield (DPS / Price) 3,88% 4,03%
Price to book (Price / BVPS) 2,40x 2,28x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 1,47% 1,43%
Operating Leverage (Delta EBIT / Delta Sales) - 0,34x
Net Margin (Net Profit / Revenue) 0,70% 0,70%
ROA (Net Profit / Asset) 3,40% 3,41%
ROE (Net Profit / Equities) 21,8% 22,0%
Rate of Dividend 55,7% 53,9%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   0,25% 0,23%
Cash Flow / Sales 1,17% 1,52%
Capital Intensity (Assets / Sales) 0,21x 0,21x
Financial Leverage (Net Debt / EBITDA) 1,85x 1,60x
EPS & Dividend